Miricor (1827.HK) jumps 32.39% pre-market HKSE 24 Mar 2026: check short-term targets

Miricor Enterprises (1827.HK) leads pre-market gainers in Hong Kong after the share price jumped 32.39% to HK$0.94 on 24 Mar 2026. The move comes on a volume spike to 30,000.00 shares versus an average of 5,862.00, suggesting short-term buying interest. Traders will watch the HKSE session for follow-through and whether the recent move reflects improved demand for Miricor’s medical aesthetic services or a technical squeeze. Our analysis covers fundamentals, technical signals, Meyka AI grading and model forecasts for 1827.HK stock.

1827.HK stock price action and drivers

Miricor (1827.HK) opened pre-market at HK$0.95 and is trading at HK$0.94, up 32.39% from the previous close of HK$0.71. Volume is 30,000.00, a relative volume of 5.12, which points to concentrated buying. One clear driver is short-term momentum after the stock tested the 50-day average of HK$0.82 and pushed above it, attracting momentum traders.

Fundamentals and valuation for 1827.HK stock

Miricor reports EPS of HK$0.03 and a reported PE near 31.33 on the latest quote, with market capitalisation of HK$376000000.00. Key ratios show price to sales 0.93 and price to book 2.55, while free cash flow yield is strong at 25.12%. These metrics suggest modest revenue scale but healthy cash generation relative to market value.

Technical setup and short-term outlook

Momentum indicators support a bullish short-term view: RSI 57.60, ADX 33.85 (strong trend) and a positive MACD histogram. Bollinger Bands sit at 0.59–0.96, placing the current price near the upper band. Support lies at the 50-day average HK$0.82 and prior pivot near HK$0.71, while resistance appears at the year high HK$1.24.

Meyka AI grade and model forecast for 1827.HK stock

Meyka AI rates 1827.HK with a score out of 100: 62.65 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of HK$0.85, quarterly HK$0.66, yearly HK$0.90. Compared with the current price HK$0.94, the yearly projection implies an implied downside of -4.49%. Forecasts are model-based projections and not guarantees.

Analyst scenarios, price targets and risks

With no formal consensus price target, we frame three scenarios: conservative target HK$0.80, base case HK$1.10, and bull case HK$1.40. These reflect valuation near price-to-sales 0.93 and the year high HK$1.24. Primary risks include demand softness for non-surgical aesthetic services, margin pressure, and a limited free float (shares outstanding 400000000.00).

Sector context and trading strategy

Miricor operates in Consumer Cyclical—Personal Products & Services—where peers trade at an average PE near 20.03 for the sector. Compared with the sector, Miricor shows stronger cash conversion and free cash flow yields but a higher PE. For traders, a disciplined entry near support HK$0.82 with a stop below HK$0.71 can manage risk while momentum persists.

Final Thoughts

Key takeaways for 1827.HK stock: Miricor’s pre-market jump to HK$0.94 on 24 Mar 2026 is driven by concentrated volume and positive technical signals, but fundamentals call for caution. Meyka AI rates the stock B (62.65), reflecting solid cash generation and operating margins but limited market scale. Meyka AI’s forecast model projects monthly HK$0.85 (implied -9.57%), quarterly HK$0.66 (implied -29.79%), and yearly HK$0.90 (implied -4.49%) versus the current price HK$0.94. Our scenarios provide analyst-style targets from HK$0.80 conservative to HK$1.40 bull. Traders should watch intraday volume and confirm breakout above HK$1.00 for sustained upside. Forecasts are model-based projections and not guarantees, and investors should weigh sector trends, Miricor’s cash metrics and operational risks before sizing positions. Meyka AI provides this analysis as an AI-powered market analysis platform to inform decisions.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.